Sonova's Innovation Crown Signals Competitive Edge in Texas Hearing Care Market
Found this article helpful?
Share it with your network and spread the knowledge!

Sonova has been named Switzerland's most innovative large company in the 2027 ranking compiled by BILANZ and PME with Statista. The honor highlights the company's advancements in AI-powered hearing technology and its Phonak brand's EON hearing aids, which are lighter, smaller, and more energy-efficient. The ranking, announced on NEWMEDIAWIRE, evaluates innovation across products, processes, and culture, placing Sonova at the top among 100 large companies.
For Texas, this recognition matters because Sonova's innovations can directly impact the state's healthcare landscape and business ecosystem. With Texas being home to a growing aging population and a vibrant healthcare sector, advanced hearing solutions like those from Sonova could enhance quality of life for residents with hearing loss. The company's AI technology, which extracts speech from background noise in real time, addresses a critical need in noisy environments such as restaurants, workplaces, and public spaces—common in Texas's bustling cities.
Eric Bernard, CEO of Sonova, emphasized the company's strategy: "We 'innovate for adoption' by turning advanced technology into solutions that people want to wear and that make hearing care easier to access and integrate into everyday life." This approach could translate into more accessible and user-friendly hearing aids for Texans, potentially reducing the stigma associated with hearing loss and encouraging more people to seek treatment. Anders Rosengren, Chief R&D Officer, added that end-to-end ownership of the technology stack allows Sonova to integrate multiple technologies into one system, driving continuous innovation.
Sonova's consistent recognition—including being ranked no. 1 among SMI companies in 2025 and no. 12 in Fortune's Europe's most innovative companies—signals a robust innovation pipeline. For Texas businesses, this could mean opportunities for partnerships, distribution, or investment in hearing care solutions. The company operates in over 100 countries and generated CHF 3.6 billion in sales in the 2025/26 financial year, with around 18,000 employees. Its brands, including Phonak, Unitron, AudioNova, and Advanced Bionics, are well-known in the hearing care industry.
The ranking by Statista on behalf of BILANZ and PME included 185 companies from start-ups to large corporations, based on expert and employee surveys and objective criteria. This independent validation of Sonova's innovative strength could bolster its reputation in Texas, where competition in healthcare technology is fierce. For readers, this news underscores the importance of innovation in addressing hearing loss, a condition affecting millions. As Sonova continues to develop AI-driven solutions, Texans can expect more personalized and seamless hearing experiences, potentially improving overall health outcomes and productivity.
For more details, visit www.sonova.com.
